WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cell treatment, is delighted to announce that it has been ranked as the 21st most disruptive company globally by DISRUPT 100.
The DISRUPT 100 is an annual index celebrating the businesses with the most potential to influence, change or create new global markets. The report tracks the world’s most disruptive businesses, compiled and curated by the world’s leading entrepreneurs, investors and business people. The list is judged by global brands including Google, Uber, Oracle, Silicon Valley Bank and Virgin StartUp, tech accelerators Microsoft Ventures, Accelerated Digital Ventures and Whitespace Ventures and entrepreneurs Emma Sinclair, Tom Goodwin and Bill Liao. For further information please go to: http://www.disrupt100.com
WideCells Group CEO, João Andrade, said, This is a momentous achievement for WideCells Group. We are delighted that our integrated stem cell support services proposition, which includes the first-of-its-kind healthcare product CellPlan, and WideAcademy, which is focused on driving education and awareness on stem cells, have been recognised as a leading force for global market change. Via our three divisions, we are focused on making stem cell treatment affordable and accessible for families around the world. With this in mind, the DISRUPT 100 is an index which reflects our aim as a Company: to be a pioneering force for change which drives investment and research into this innovative industry. We believe that we are reaching a tipping point in terms of market understanding of its huge potential to treat rare and life-threatening conditions and are proud to be recognised as an intrinsic part of this medical revolution.